Exact Mass: 506.2628
Exact Mass Matches: 506.2628
Found 270 metabolites which its exact mass value is equals to given mass value 506.2628
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
4-Megastigmene-6a,9R-diol 9-[apiosyl-(1->6)-glucoside]
4-Megastigmene-6a,9R-diol 9-[apiosyl-(1->6)-glucoside] is found in fruits. 4-Megastigmene-6a,9R-diol 9-[apiosyl-(1->6)-glucoside] is a constituent of Cydonia vulgaris (quince). Constituent of Cydonia vulgaris (quince). 4-Megastigmene-6a,9R-diol 9-[apiosyl-(1->6)-glucoside] is found in fruits.
(3b,9R)-5-Megastigmene-3,9-diol 9-[apiosyl-(1->6)-glucoside]
(3b,9R)-5-Megastigmene-3,9-diol 9-[apiosyl-(1->6)-glucoside] is found in tea. (3b,9R)-5-Megastigmene-3,9-diol 9-[apiosyl-(1->6)-glucoside] is a constituent of leaves of Camellia sinensis var. sinensis (China tea). Constituent of leaves of Camellia sinensis variety sinensis (China tea). (3b,9R)-5-Megastigmene-3,9-diol 9-[apiosyl-(1->6)-glucoside] is found in tea.
Abemaciclib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EF - Cyclin-dependent kinase (cdk) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
(3R,9S)-megastigman-5-en-3,9-diol 3-O-[alpha-L-arabinofuranosyl-(1->6)]-beta-D-glucopyranoside
6beta-cinnamoyloxy-7beta-acetoxyvouacapen-5alpha-ol
7-megastigmen-3-ol-9-one 3-O-alpha-L-arabinofuranosyl-(1?6)-beta-D-glucopyranoside
(2R,9R)-megastigman-5-en-2,9-diol 9-O-alpha-L-arabinopyranosyl(1->6)-beta-D-glucopyranoside|foliasalacioside I
Asn Phe Ala Arg
C24H42O11_beta-D-Glucopyranoside, (1S,4R,5R)-4-[(1E,3R)-3-hydroxy-1-buten-1-yl]-3,3,5-trimethylcyclohexyl 6-O-[(2R,3R,4R)-tetrahydro-3,4-dihydroxy-4-(hydroxymethyl)-2-furanyl]
Ala Phe Asn Arg
Ala Phe Arg Asn
Ala Asn Phe Arg
Ala Asn Arg Phe
Ala Arg Phe Asn
Ala Arg Asn Phe
Cys Lys Arg Thr
Cys Lys Thr Arg
Cys Arg Lys Thr
Cys Arg Thr Lys
Cys Thr Lys Arg
Cys Thr Arg Lys
Phe Ala Asn Arg
Phe Ala Arg Asn
Phe Phe Pro Pro
Phe Gly Gln Arg
Phe Gly Arg Gln
Phe Ile Met Pro
Phe Ile Pro Met
Phe Leu Met Pro
Phe Leu Pro Met
Phe Met Ile Pro
Phe Met Leu Pro
Phe Met Pro Ile
Phe Met Pro Leu
Phe Asn Ala Arg
Phe Asn Arg Ala
Phe Pro Phe Pro
Phe Pro Ile Met
Phe Pro Leu Met
Phe Pro Met Ile
Phe Pro Met Leu
Phe Pro Pro Phe
Phe Gln Gly Arg
Phe Gln Arg Gly
Phe Arg Ala Asn
Phe Arg Gly Gln
Phe Arg Asn Ala
Phe Arg Gln Gly
Gly Phe Gln Arg
Gly Phe Arg Gln
Gly Gln Phe Arg
Gly Gln Arg Phe
Gly Arg Phe Gln
Gly Arg Gln Phe
His His Ile Thr
His His Leu Thr
His His Thr Ile
His His Thr Leu
His Ile His Thr
His Ile Thr His
His Leu His Thr
His Leu Thr His
His Thr His Ile
His Thr His Leu
His Thr Ile His
His Thr Leu His
Ile Phe Met Pro
Ile Phe Pro Met
Ile His His Thr
Ile His Thr His
Ile Ile Met Met
Ile Leu Met Met
Ile Met Phe Pro
Ile Met Ile Met
Ile Met Leu Met
Ile Met Met Ile
Ile Met Met Leu
Ile Met Pro Phe
Ile Pro Phe Met
Ile Pro Met Phe
Ile Thr His His
Lys Cys Arg Thr
Lys Cys Thr Arg
Lys Arg Cys Thr
Lys Arg Thr Cys
Lys Thr Cys Arg
Lys Thr Arg Cys
Leu Phe Met Pro
Leu Phe Pro Met
Leu His His Thr
Leu His Thr His
Leu Ile Met Met
Leu Leu Met Met
Leu Met Phe Pro
Leu Met Ile Met
Leu Met Leu Met
Leu Met Met Ile
Leu Met Met Leu
Leu Met Pro Phe
Leu Pro Phe Met
Leu Pro Met Phe
Leu Thr His His
Met Phe Ile Pro
Met Phe Leu Pro
Met Phe Pro Ile
Met Phe Pro Leu
Met Ile Phe Pro
Met Ile Ile Met
Met Ile Leu Met
Met Ile Met Ile
Met Ile Met Leu
Met Ile Pro Phe
Met Leu Phe Pro
Met Leu Ile Met
Met Leu Leu Met
Met Leu Met Ile
Met Leu Met Leu
Met Leu Pro Phe
Met Met Ile Ile
Met Met Ile Leu
Met Met Leu Ile
Met Met Leu Leu
Met Pro Phe Ile
Met Pro Phe Leu
Met Pro Ile Phe
Met Pro Leu Phe
Asn Ala Phe Arg
Asn Ala Arg Phe
Asn Phe Arg Ala
Asn Arg Ala Phe
Asn Arg Phe Ala
Pro Phe Phe Pro
Pro Phe Ile Met
Pro Phe Leu Met
Pro Phe Met Ile
Pro Phe Met Leu
Pro Phe Pro Phe
Pro Ile Phe Met
Pro Ile Met Phe
Pro Leu Phe Met
Pro Leu Met Phe
Pro Met Phe Ile
Pro Met Phe Leu
Pro Met Ile Phe
Pro Met Leu Phe
Pro Pro Phe Phe
Gln Phe Gly Arg
Gln Phe Arg Gly
Gln Gly Phe Arg
Gln Gly Arg Phe
Gln Arg Phe Gly
Gln Arg Gly Phe
Arg Ala Phe Asn
Arg Ala Asn Phe
Arg Cys Lys Thr
Arg Cys Thr Lys
Arg Phe Ala Asn
Arg Phe Gly Gln
Arg Phe Asn Ala
Arg Phe Gln Gly
Arg Gly Phe Gln
Arg Gly Gln Phe
Arg Lys Cys Thr
Arg Lys Thr Cys
Arg Asn Ala Phe
Arg Asn Phe Ala
Arg Gln Phe Gly
Arg Gln Gly Phe
Arg Thr Cys Lys
Arg Thr Lys Cys
Thr Cys Lys Arg
Thr Cys Arg Lys
Thr His His Ile
Thr His His Leu
Thr His Ile His
Thr His Leu His
Thr Ile His His
Thr Lys Cys Arg
Thr Lys Arg Cys
Thr Leu His His
Thr Arg Cys Lys
Thr Arg Lys Cys
(5Z,7E,22E)-(3S)-26,26,26,27,27,27-hexafluoro-9,10-seco-5,7,10(19),22-cholestatetraene-3,25-diol
(3b,9R)-5-Megastigmene-3,9-diol 9-[apiosyl-(1->6)-glucoside]
4-Megastigmene-6a,9R-diol 9-[apiosyl-(1->6)-glucoside]
(22E)-26,26,26,27,27,27-hexafluoro-25-hydroxy-22,23-didehydrovitamin D3
(R)-5-(2-(benzyl(4-phenylbutan-2-yl)amino)acetyl)-2-(benzyloxy)benzamide
5-(di-tert-Butylphosphino)-1,3,5-triphenyl-1h-[1,4]bipyrazole
Abemaciclib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EF - Cyclin-dependent kinase (cdk) inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C2185 - Cyclin-Dependent Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent
1-Hexadecanoyl-2-(5-oxopentanoyl)-sn-glycero-3-phosphate
N-[[(2S,3R)-8-(3-cyanophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-4-oxanecarboxamide
N-[[(2S,3S)-8-(3-cyanophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-4-oxanecarboxamide
N-[[(2R,3S)-8-(3-cyanophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-4-oxanecarboxamide
N-[[(2S,3R)-8-(3-cyanophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-4-oxanecarboxamide
N-[[(2R,3S)-8-(3-cyanophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-4-oxanecarboxamide
N-[[(2S,3S)-8-(3-cyanophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-4-oxanecarboxamide
N-[[(2R,3R)-8-(3-cyanophenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-4-oxanecarboxamide
N-[[(2R,3R)-8-(3-cyanophenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-4-oxanecarboxamide
[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
1-(6Z,9Z,12Z-octadecatrienoyl)-glycero-3-phospho-(1-sn-glycerol)
(2s,3r,4s,5s,6r)-2-{[(1r)-4-[(3r)-3-hydroxybutyl]-3,5,5-trimethylcyclohex-3-en-1-yl]oxy}-6-({[(2r,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol
(2r,3s,4s,5r,6s)-2-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-{[(2r)-4-[(1s)-1-hydroxy-2,6,6-trimethylcyclohex-2-en-1-yl]butan-2-yl]oxy}oxane-3,4,5-triol
2-({[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-{[4-(4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl)butan-2-yl]oxy}oxane-3,4,5-triol
(2r,3s,4s,5r,6r)-2-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-{[(1r)-4-[(3s)-3-hydroxybutyl]-3,5,5-trimethylcyclohex-3-en-1-yl]oxy}oxane-3,4,5-triol
(2r,3r,4s,5r,6r)-2-({[(2s,3s,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-6-{[(2r)-4-[(4s)-4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]butan-2-yl]oxy}oxane-3,4,5-triol
(2r,3r,4s,5s,6r)-2-{[(1s)-4-[(3r)-3-hydroxybutyl]-3,5,5-trimethylcyclohex-3-en-1-yl]oxy}-6-({[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol
(3r,9s)-megastigman-5-en-3,9-diol-3-o-[α-l-arabinofuranosyl-(1→6)]-β-d-glucopyranoside
{"Ingredient_id": "HBIN009576","Ingredient_name": "(3r,9s)-megastigman-5-en-3,9-diol-3-o-[\u03b1-l-arabinofuranosyl-(1\u21926)]-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C24H42O11","Ingredient_Smile": "CC1=C(C(CC(C1)OC2C(C(C(C(O2)COC3C(C(C(O3)CO)O)O)O)O)O)(C)C)CCC(C)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13635","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}